Search PubMed⌕ Search

Biomedical subjects

G Decker

Publications and source records attributed to G Decker.

51 records · Page 3Linked to original sources

Retrograde intraoperative gastroscopy in obscure bleeding of the gastrointestinal tract.

Intraoperative endoscopic localization of the lesions responsible for the bleeding in the upper part of the gastrointestinal tract that escape detection in the preoperative period is an attractive alternative to the blind exploratory duodenogastrostomy. The retrograde technique described herein may be superior to the oral antegrade intraoperative method advocated by some authors. Large clots obscuring clear viewing are rapidly removed by way of the small gastrotomy, and the proximal hidden corners of the stomach are readily visualized even by a surgeon who lacks previous experience with endoscopic techniques. We suggest this to be the method of choice for localization of the obscure point of bleeding during emergent operations for bleeding of the upper part of the gastrointestinal tract.

Emergencies↗

Intraoperative peritoneal lavage.

The successful management of the contaminated or septic abdomen rests on at least three tenets: The use of systemic perioperative antibiotics, the control of the source of infection and the aspiration of the gross contaminants. The additional use of any modality of IOPL is well entrenched in modern surgical practice. It does, however, owe more to force of habit or prejudice than to sound scientific evidence. Most, if not all, experimental or clinical studies suggesting the benefits of IOPL suffer from many deficiencies, some of which we made a point of emphasizing. In broad terms, one could recognize three major pitfalls invalidating these studies. First, the design of some of the experimental studies bears no resemblance to clinical situations. For example, laparotomy was omitted in either both arms of the trial or in the control arm. Second, far too frequently, the data were drawn from retrospective or uncontrolled trials. Although the value of such studies cannot be denied, the literature is replete with examples of perpetuation of erroneuos concepts through lack of properly designed prospective, randomized controlled studies. Third, many of the trials were performed before the revolutionary introduction of perioperative antibiotics in clinical practice. Of greater concern is the existence of studies which, for unexplained reasons, have ignored this principle. From this review, it seems that neither the benefit nor the safety of IOPL with crystalloid or antiseptic solution has been established beyond any reasonable doubt. The theory for the addition of judicious antibiotics to the IOPL may be stronger, although no absolute proof exists to suggest that this practice will decrease mortality rates from intra-abdominal infections. Obviously, there is a need for well constructed, controlled, prospective clinical trials to examine the role of IOPL in modern surgical groups of patients assembled under the label intra-abdominal infection. Until some stratification of peritonitis in various clinical studies is undertaken, either by how ill the patient is or the source of contamination and its duration, it will be difficult to compare studies from different centers.

Humans↗

[Immunologic and clinical findings in different liver diseases (statistical studies)].

In 140 out-patients of a liver dispensary department 18 clinical and immunological markers (autoantibodies) in 7 well defined diseases were found. We them underwent to a multiple linear factor analysis. 4 different and independent structural factors could be defined: 1. a so-called autoimmunity factor, 2. a parenchymatous factor, 3. an ethanol factor and, finally, a dysproteinemia factor. By individual factor analysis different hepatological diseases could be characterized.

Adult↗

Colonic necrosis in acute pancreatitis. A complication of massive retroperitoneal suppuration.

Colonic necrosis is a rare complication of peripancreatic sepsis following acute pancreatitis. Three patients with colonic necrosis associated with extensive retroperitoneal suppuration are reported. The pathogenesis of this syndrome may be explained by the tendency of pancreatic abscesses to extend widely in the retroperitoneum. Management is discussed, emphasizing the need for an aggressive surgical approach and multiple operations.

Abscess↗

A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass.

General surgical complications after cardiopulmonary bypass (CPB) are infrequent but serious. No prospective studies have evaluated their incidence. We analyzed in such a study 135 patients who were to undergo CPB. Among these 135 patients, an abdominal complication developed in 6.6%; it contributed to 2 of the 5 deaths. Postoperative hyperamylasemia was found in 36% of patients, but only 2 had overt pancreatitis. The hyperamylasemia was not due to the salivary component, pulmonary complications, or prolonged CPB (r = 0.22). A gastrointestinal hemorrhage occurred in 7 patients. No patients had acute cholecystitis. We conclude that abdominal complications are more frequent than reported in retrospective studies, and result in significant morbidity and mortality. Postoperative hyperamylasemia is common but usually is not associated with untoward morbidity or mortality.

Adult↗

Glycoproteins of coated pits, cell junctions, and the entire cell surface revealed by monoclonal antibodies and immunoelectron microscopy.

Topographical descriptions of three major plasma membrane glycoproteins of murine 3T3 cells were obtained by immunoelectron microscopy with monoclonal antibodies. A glycoprotein of Mr 80,000 was distributed throughout the total cell surface. A second of Mr 90,000 was concentrated in coated pits, and a third of Mr 100,000 was localized at cell junctions.

Animals↗

A new acrosin inhibitor from boar spermatozoa.

A new proteinase inhibitor (Mr 7500) was isolated to apparent homogeneity from boar spermatozoa by repeated gel filtration on Sephadex G-50 and affinity chromatography on concanavalin-A--Sepharose 4B. The inhibitor strongly inhibits boar acrosin in a competitive 1:1 stoichiometric reaction with Kass = 7 x 10(10)1 mol-1. The inhibitor is a glycoprotein and represents a first member of a new class of proteinase inhibitor with a rather short polypeptide backbone of only 42 amino acid residues and a low cystine content. The basic protein (isoelectric point 9.4) contains a single disulfide loop, which is easily reducible by sodium borohydride. Upon reduction the inhibitory activity is lost, but rapidly regained after air reoxidation of the corresponding half-cystine residues. The reactive site residue was established to be arginine by inhibition with 2,3-butanedione. The inhibitor is rather specific for acrosin and inhibits bovine trypsin only to a limited extent. However, incubation with catalytic amounts of trypsin (or acrosin) at acid pH (pH2-3) rapidly leads to a limited proteolysis at the reactive site with formation of 67% modified (reactive site hydrolysed), but still active inhibitor. The equilibrium constant was established to be Khyd = 2.0.

Acrosin↗

Sleeve lobectomy for non-small cell lung cancer.

UNLABELLED: Sleeve lobectomy is a procedure in which the involved lobe with part of the main stembronchus is removed. The remaining lobe (s) is reimplanted on the main stembronchus. This procedure is indicated for central tumors of the lung as an alternative to pneumonectomy. It is the aim of this study to describe the technique of sleeve lobectomy and to analyse the early postoperative results and late results (survival-recurrence) after sleeve lobectomy for non-small-cell lung cancer. MATERIAL AND METHODS: Between 1985 and 1999, 77 sleeve lobectomies for bronchogenic carcinoma were performed at the University hospitals Leuven. The most common performed sleeve lobectomy is the right upper lobe sleeve lobectomy (67.5%). In 6 patients a combined sleeve resection of the pulmonary artery was performed. The operative mortality was 3.9%. Two patients developed a broncho-pleural fistula. The five-year survival rate was 45.6%. In 5 patients, an anastomotic suture developed which required a completion pneumonectomy in 2. Thirteen patients developed local tumor recurrence. CONCLUSION: We conclude that sleeve lobectomy can be performed with an acceptable mortality and morbidity. Long term survival rate and recurrence rate are as good as after pneumonectomy. The operative mortality is lower when compared to pneumonectomy, exercise tolerance and quality of life are much better after sleeve lobectomy compared to pneumonectomy. For central tumours we believe that sleeve resection is the procedure of choice.

Adult↗

Treatment of choledocholithiasis: therapeutic ERCP versus peroperative extraction during laparoscopic cholecystectomy.

Limitation for preoperative ERCP/ES before laparoscopic cholecystectomy in patients scheduled for laparoscopic cholecystectomy are (1) Additional invasiveness of endoscopic procedures in patients supposed to be fitted for surgery, (2) A high rate of useless procedures due to the low predictive value of suspicion criteria for common bile duct stones (CBDS), (3) an inability to detect and treat all patients with CBDS, and (4) so far, an absence of demonstration of the superiority of this split therapeutic approach versus a one stage surgical treatment. Published series of CBDS extraction during laparoscopic cholecystectomy have included more than 2000 patients. Results and complications of this one stage laparoscopic approach compares favourably to the conventional open surgical treatment. In one randomized trial endoscopy plus laparoscopy was not demonstrated superior to laparoscopy alone. Intraoperative diagnosis and treatment of CBDS during laparoscopic cholecystectomy is the most cost efficient approach for patients with or without preoperative suspicion of CBDS, provide they are fitted for surgery.

Cholangiopancreatography, Endoscopic Retrograde↗

Laparoscopic cholecystectomy for acute cholecystitis in geriatric patients.

Although acute cholecystitis (AC) in many centers is routinely treated by laparoscopic cholecystectomy (LC), the outcome of LC for AC in geriatric patients (75 years or more) remains almost unstudied. All 32 geriatric patients undergoing a cholecystectomy for histologically proven AC in a teaching hospital during a six-year period were studied retrospectively. Median preoperative duration of symptoms was eight days and median preoperative hospital stay was six days. Preoperative ERCP was performed in 22 patients with successful sphincterotomy and common bile duct (CBD) stone retrieval in 11 patients. Overall twelve patients (37%) had CBD stones and 14 patients (44%) had gangrenous cholecystitis at operation. Twenty-seven patients underwent a LC with a conversion rate of 26%, a complication rate of 41% and a mortality rate of 3.7%. Five patients were judged unstable for a laparoscopic approach and underwent a straight open cholecystectomy. Although the latter were at higher risk (higher APACHE II scores), their outcome except for longer intensive care unit stays, was not different from laparoscopically treated patients. Lack of superiority of laparoscopic over open cholecystectomy in the present study seemed due to clinical characteristics of AC in geriatric patients which may lead to late diagnosis and treatment. Preoperative ERCP by further delaying surgery may contribute to loose any potential benefit of an early laparoscopic procedure. The place of preoperative ERCP and the timing of LC in geriatric patients with AC therefore may need to be redefined.

APACHE↗

Patients are talking about ... Iscador (mistletoe).

Mistletoe generally is categorized as American mistletoe or European mistletoe. Despite its well-known potential for toxicity, mistletoe continues to be used as an herbal remedy and recently has received a great deal of media attention. The U.S. Food and Drug Administration classified mistletoe as a food additive that cannot be marketed unless proven safe for consumption (DerMarderosian, 1992). Several components of the plant have been found to possess antineoplastic activity and warrant further investigation for their clinical potential. At this time, however, mistletoe as a single-agent therapy has not been scientifically validated in the treatment of breast cancer.

Antineoplastic Agents↗